SNHG14 promotes CRC progression by negatively regulating EPHA7 through an EZH2-dependent pathway, enhancing methylation on the EPHA7 promoter, and stabilizing EZH2 mRNA by interacting with FUS and freeing it from miR-186-5p-induced silence. Here, SNHG14 is linked to colorectal carcinoma.